The impact of comparability on orphan drug development

As we've been hearing from pharma and biotech executives in the rare disease space in recent years, market access is a key element in supporting the expansion and development of orphan drugs around the globe. This issue is really dynamic as it is impacted by challenges from the very early drug discovery stage, to clinical trials, manufacturing and consequently the …